Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Lancet Regional Health. Western Pacific|December 26, 2025
Clinical decision rules for diagnosis of Streptococcus pyogenes sore throat in Fiji: a prospective diagnostic accuracy studyJohn D Hart, Jimaima Kailawadoko, Tria Williams, et al.
Plos Neglected Tropical Diseases|June 21, 2013
Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the GambiaEmma M Harding-Esch, Ansumana Sillah, Tansy Edwards, et al.
BMC Medicine|March 10, 2020
Improving medical certification of cause of death: effective strategies and approaches based on experiences from the Data for Health InitiativeJohn D Hart, Renee Sorchik, Khin Sandar Bo, et al.
The Lancet. Infectious Diseases|June 5, 2025
Long-term effects of azithromycin mass administration to reduce childhood mortality on Streptococcus pneumoniae antimicrobial resistance: a population-based, cross-sectional, follow-up carriage surveyAkuzike Kalizang'oma, Jia Mun Chan, Khumbo Kalua, et al.
Vaccine|October 10, 2025
Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trialTsetsegsaikhan Batmunkh, Eleanor F G Neal, Otgonjargal Amraa, et al.
The Lancet Regional Health. Western Pacific|February 15, 2024
Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trialTsetsegsaikhan Batmunkh, Kerryn A Moore, Helen Thomson, et al.
Frontiers in Immunology|April 8, 2026
Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trialTsetsegsaikhan Batmunkh, Eleanor Fg Neal, Otgonjargal Amraa, et al.
Nature Communications|September 29, 2025
Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trialJohn D Hart, Eddy Fadlyana, Nadia Mazarakis, et al.
Lancet Regional Health. Americas|February 13, 2023
Validation of SmartVA using conventional autopsy: A study of adult deaths in BrazilJohn D Hart, Paulo Afonso de André, Carmen Diva Saldiva de André, et al.
Pageof 3